Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Telix Pharmaceuticals Limited - American Depositary Shares
(NQ:
TLX
)
10.87
+0.32 (+3.03%)
Delayed Quote
Updated: 1:45 PM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Telix Pharmaceuticals Limited - American Depositary Shares
< Previous
1
2
3
4
5
6
7
8
Next >
Telix FAP-targeting Therapeutic Published in Thyroid Journal: Demonstrates Encouraging Efficacy
May 07, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Telix's Illuccix PSMA-PET Imaging Agent Approved in France
April 28, 2025
New approval provides French hospitals and clinics with access to a proven PSMA-PET imaging agent
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Telix Reports US$186M Q1 Revenue, Up 62% YOY
April 22, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Telix Pharmaceuticals Touts Encouraging Data From Investigational Radiation Therapy In Relapsed Brain Cancer Patients
↗
April 16, 2025
Telix reports early Phase 2 data showing TLX101 improves survival in recurrent brain cancer patients, with no serious side effects observed.
Via
Benzinga
IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy Candidate
April 15, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
These Mid-Cap Stocks Outshone The Market Volatility Last Week (Apr 7-Apr 11): Are These In Your Portfolio?
↗
April 13, 2025
Top mid-cap stock performers last week: AGL, RXRX, CERT, AVAV, STRL, ORLA, IAG, SBSW, LOAR, RYTM, TLX. High gains due to positive news and macro uncertainty.
Via
Benzinga
Telix Announces Cardinal Health for Gozellix Commercial Distribution
April 08, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Five Below, Telix Pharmaceuticals, Dollar Tree And Other Big Stocks Moving Higher On Monday
↗
April 07, 2025
Via
Benzinga
Telix Appoints Paul Schaffer as Chief Technology Officer
April 07, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Anne Whitaker Appointed as Non-Executive Director
April 03, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Telix Announces First Patient Dosed in First-in-Human ZOLAR Trial of TLX300-CDx in Advanced Soft Tissue Sarcoma
April 01, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
ARTMS Drug Master File for Gallium Production Technology Referenced with Telix’s Gozellix®
April 01, 2025
From
Telix ARTMS, Inc.
Via
GlobeNewswire
FDA Approves New Prostate Cancer Imaging Agent Gozellix®
March 21, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America
March 17, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Telix Adds Lead-212 Isotope Production Capability
March 12, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Investor Webinar: Telix Therapeutics Urology Showcase and Expert Forum
March 03, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review
February 25, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Recruitment Spotlight: Phase 3 Clinical Trial of Novel Prostate Cancer Radiopharmaceutical Now Active in Miami
February 25, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Bridge Investment Group, Telix Pharmaceuticals, Sun Communities, And Other Big Stocks Moving Higher On Monday
↗
February 24, 2025
Via
Benzinga
Stock Rebound Stalls; Nasdaq Down Triple Digits
↗
February 24, 2025
Stocks have pulled back from their premarket gains, with the Nasdaq Composite down 163 points and oscillating in and out of negative territory for 2025.
Via
Talk Markets
Topics
Stocks
Stocks / Equities
Telix 2024 Full Year Results: Record Financial Performance and Investment in Future Growth, FY2025 Guidance of up to $1.23 Billion
February 20, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Telix to Showcase Urology Pipeline at Upcoming ASCO Genitourinary Cancers Symposium (ASCO GU 2025)
February 13, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Illuccix® Approved in the United Kingdom
February 12, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
February 10, 2025
Via
Benzinga
Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
January 30, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Telix Completes Acquisition of RLS (USA) Inc.
January 27, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
SLB Posts Upbeat Results, Joins Bank OZK, Qorvo And Other Big Stocks Moving Higher On Friday
↗
January 17, 2025
Via
Benzinga
Illuccix® Receives European Approval
January 16, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Telix Presentation to the 43rd Annual J.P. Morgan Healthcare Conference
January 13, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Telix Exceeds FY24 Guidance with US$142M Q4 Revenue
January 13, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
